Transcranial Magnetic Stimulation to Measure Cortical Excitability in Dravet Syndrome
Sponsor: Boston Children's Hospital
Listed as NCT04614506, this observational or N/A phase trial focuses on Dravet Syndrome and remains ongoing. Sponsored by Boston Children's Hospital, it has been updated 9 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Apr 2024 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Apr 2022 — Apr 2024 [monthly]
Recruiting
-
Mar 2022 — Apr 2022 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Dec 2021 — Mar 2022 [monthly]
Recruiting
-
Mar 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting
First recorded
Nov 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boston Children's Hospital
- Encoded Therapeutics
For direct contact, visit the study record on ClinicalTrials.gov .